Karen A. Dawes, Director at Assertio Therapeutics, Inc (ASRT), sold 8,421 shares at $4.84 ($41K) on 2018-12-03, disclosed to the SEC on 2018-12-04.
Open-market sale of $41k ASRT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |